Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Predictive biomarkers for immune-related adverse events in cancer patients treated with immune-checkpoint inhibitors ; volume:25 ; number:1 ; day:24 ; month:1 ; year:2024 ; pages:1-13 ; date:12.2024
BMC immunology ; 25, Heft 1 (24.1.2024), 1-13, 12.2024
- Creator
-
Wang, Jingting
Ma, Yan
Lin, Haishan
Wang, Jing
Cao, Bangwei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12865-024-00599-y
- URN
-
urn:nbn:de:101:1-2024040509421226235877
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Jingting
- Ma, Yan
- Lin, Haishan
- Wang, Jing
- Cao, Bangwei
- SpringerLink (Online service)
Other Objects (12)
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis
Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
Managing immune-related adverse events in oncology
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis
Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
Managing immune-related adverse events in oncology
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events
Immune-related adverse events of COVID-19 vaccination in skin cancer patients receiving immune-checkpoint inhibitor treatment
Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors
Steroid-Refractory Immune-Related Adverse Events Induced by Checkpoint Inhibitors
Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series
Immune-related serious adverse events with immune checkpoint inhibitors: Systematic review and network meta-analysis
Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis
Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea
Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
Managing immune-related adverse events in oncology
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse events